Bristol-Myers Squibb Rights
CELG.RT
18 hedge funds and large institutions have $169K invested in Bristol-Myers Squibb Rights in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
1% more capital invested
Capital invested by funds: $167K → $169K (+$2K)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
5% less funds holding
Funds holding: 19 → 18 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.25K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$680 |
| 3 |
Morgan Stanley
New York
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$94 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FCM
1
FourWorld Capital Management
New York
| $69K | – | – | – |
|
|
MS
2
Maven Securities
St Helier,
Jersey
| $47K | – | – | – |
|
|
TCA
3
Transcend Capital Advisors
Madison,
New Jersey
| $15K | – | – | – |
|
|
DC
4
Davenport & Co
Richmond,
Virginia
| $13K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $9K | +$1.25K | +8,998 | +16% |
|
|
6
Citadel Advisors
Miami,
Florida
| $5K | -$94 | -675 | -2% |
|
|
7
UBS Group
Zurich,
Switzerland
| $4K | +$680 | +4,894 | +22% |
|
8
Fifth Third Bancorp
Cincinnati,
Ohio
| $3K | – | – | – |
|
|
PAG
9
Private Advisor Group
Morristown,
New Jersey
| $2K | – | – | – |
|
|
TPA
10
Trivium Point Advisory
Westport,
Connecticut
| $2K | – | – | – |
|
|
11
Morgan Stanley
New York
| – | +$8 | +59 | +56% |
|
CELG.RT Hedge Fund Activity: Q3 2022 in Review
18 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q3 2022, worth a combined $169K — up 1.2% from $167K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CELG.RT and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $1.25K. The largest seller was Citadel Advisors, cutting an estimated $94.
- 18 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q3 2022, down from 19 in Q2 2022.
- Funds reported $169K of Bristol-Myers Squibb Rights stock for Q3 2022, up 1.2% quarter-over-quarter.
- 0 funds opened new Bristol-Myers Squibb Rights positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Bristol-Myers Squibb Rights buyer in Q3 2022 was Susquehanna International Group, an estimated $1.25K added.
- The largest Bristol-Myers Squibb Rights seller in Q3 2022 was Citadel Advisors, an estimated $94 sold.
Based on aggregated 13F filings for Q3 2022.